NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
10.79
+0.05 (0.47%)
At close: Oct 21, 2025, 4:00 PM EDT
10.85
+0.06 (0.56%)
After-hours: Oct 21, 2025, 4:56 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $354.8 million as of October 21, 2025. Its market cap has increased by 74.85% in one year.
Market Cap
354.80M
Enterprise Value
367.65M
1-Year Change
74.85%
Ranking
Category
Stock Price
$10.79
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $354.80M, a decrease of -9.78%. That is a compound annual growth rate of -2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 355.30M | 6.38% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |